Dr. Todd D. Tillmanns
Claim this profileThe West Clinic, PLLC dba West Cancer Center
Area of expertise
Endometrial Cancer
Todd D. Tillmanns has run 2 trials for Endometrial Cancer. Some of their research focus areas include:
Endometrial Adenocarcinoma
Todd D. Tillmanns has run 1 trial for Endometrial Adenocarcinoma. Some of their research focus areas include:
Affiliated Hospitals
The West Clinic, PLLC Dba West Cancer Center
The West Clinic - Wolf River
Clinical Trials Todd D. Tillmanns is currently running
Selinexor Maintenance Therapy
for Endometrial Cancer
The purpose of this study is to evaluate the efficacy and safety of selinexor as a maintenance treatment in patients with p53 wt endometrial carcinoma (EC), who have achieved a partial response (PR) or complete response (CR) (per Response Evaluation Criteria in Solid Tumors version 1.1 \[RECIST v 1.1\]) after completing at least 12 weeks of platinum-based therapy. A total of 276 participants will be enrolled in the study and randomized in a 1:1 ratio to maintenance therapy with either selinexor or placebo.
Recruiting
1 award
Phase 3
2 criteria
Herceptin Hylecta or Phesgo + Chemotherapy
for Uterine Cancer
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Recruiting
2 awards
Phase 3
More about Todd D. Tillmanns
Clinical Trial Related
2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Todd D. Tillmanns has experience with
- Selinexor
- Carboplatin
- Paclitaxel
- Pertuzumab
- Trastuzumab
Breakdown of trials Todd D. Tillmanns has run
Endometrial Cancer
Endometrial Adenocarcinoma
Uterine Carcinosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Todd D. Tillmanns specialize in?
Todd D. Tillmanns focuses on Endometrial Cancer and Endometrial Adenocarcinoma. In particular, much of their work with Endometrial Cancer has involved HER2 positive patients, or patients who are Stage I.
Is Todd D. Tillmanns currently recruiting for clinical trials?
Yes, Todd D. Tillmanns is currently recruiting for 2 clinical trials in Germantown Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Todd D. Tillmanns has studied deeply?
Yes, Todd D. Tillmanns has studied treatments such as Selinexor, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Todd D. Tillmanns?
Apply for one of the trials that Todd D. Tillmanns is conducting.
What is the office address of Todd D. Tillmanns?
The office of Todd D. Tillmanns is located at: The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee 38138 United States. This is the address for their practice at the The West Clinic, PLLC dba West Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.